Tag: drug
Union S&T Minister emphasizes criticality of digital medicine
Tele-medicine and robotic surgery have already taken over in a big way and the indispensable utility of these new options was realised during the pandemic times, noted Dr Jitendra Singh
New study by BHU scientists raises prospect of Zika virus therapy
A team of researchers has found that the virus interacts with a set of cells called microglial cells, which protect the brain from infections and that a protein in the virus called ZIKV-NS1 plays an important role in its replication and immune evasion
CSIR-CDRI transfers tech to Marc Labs, aims to develop safer drug...
Central Drug Research Institute has recently obtained the permission to initiate the Phase I clinical trials for the new safer drug for heart attack and stroke expected to be in the market soon
Dr. Srivari Chandrasekhar takes charge as the new DST secretary
Before heading Department of Science and Technology, Dr. Chandrashekhar was until recently Director of CSIR’s Indian Institute of Chemical Technology (IICT) at Hyderabad
Zydus gets go ahead for phase-2 clinical trial of its novel...
The company will soon begin the Phase II (a) clinical trial of ZYIL1, a novel oral NLRP3 inflammasome inhibitor in patients with Cryopyrin-Associated Periodic Syndrome (CAPS), a rare life-long auto-inflammatory condition in Australia
Monoclonal antibody therapy prevents severe Covid-19 deaths: AIG Hospitals’ study
Study conducted on 285 high-risk individuals and published in the International Journal of Internal Medicine successfully proved that the Monoclonal Therapy reduces severe disease and death in high-risk individuals infected with the Delta Variant of SARS CoV 2...................
Top 5 pharma majors collaborate to conduct clinical trial of anti-viral...
Cipla, Dr. Reddy’s, Emcure, Sun Pharma and Torrent to collaborate for clinical trial of investigational anti-viral drug Molnupiravir for COVID-19...........................
New drug for coronary diseases could be in offing
An agreement between CSIR-CDRI and Marc Laboratories could pave the way for developing a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen-induced platelet aggregation....................
Biotech startup, CyGenica secures USD $1.4 million funding from SOSV
The funding round will accelerate validation of CyGenica’s proprietary technology which enables safe, targeted and affordable intercellular drug delivery.............................
Cipla signs COVID-19 drug licensing deal with MSD
Cipla enters into a licensing agreement with MSD to expand access to the investigational oral therapeutic drug for COVID-19 treatment...........................